Jabasa, Baby Boy .
HRN: 28-15-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2025
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
11/27/2025
11/30/2025
PO
2ml
BID
PCAP
Checking Final Appropriateness
Indication: ProphylaxisEmpiricEmpirical De-escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes